雷珠单抗与贝伐单抗的比较。 - Suppr

Suppr

超能文献

Comparing ranibizumab with bevacizumab.

作者信息

Biswas Partha, Sengupta Subhrangshu, Choudhary Ruby, Home Subhankar, Paul Ajoy, Sinha Sourav

出版信息

Ophthalmology. 2011 Mar;118(3):600-600.e2. doi: 10.1016/j.ophtha.2010.10.027.

DOI:10.1016/j.ophtha.2010.10.027

PMID:21376243

Abstract

摘要

相似文献

Comparing ranibizumab with bevacizumab.雷珠单抗与贝伐单抗的比较。

Ophthalmology. 2011 Mar;118(3):600-600.e2. doi: 10.1016/j.ophtha.2010.10.027.

Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration.玻璃体内注射贝伐单抗治疗渗出性年龄相关性黄斑变性所致视乳头旁脉络膜新生血管

Acta Ophthalmol. 2011 Feb;89(1):e105-7. doi: 10.1111/j.1755-3768.2009.01820.x.

The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system.脉络膜新生血管的按需治疗策略：一种基于反馈的治疗系统。

Am J Ophthalmol. 2009 Jul;148(1):1-3. doi: 10.1016/j.ajo.2009.04.010.

A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.雷珠单抗治疗初治的年龄相关性黄斑变性继发非黄斑中心凹脉络膜新生血管的1年回顾性研究

Retina. 2009 Nov-Dec;29(10):1444-9. doi: 10.1097/IAE.0b013e3181ae712d.

Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.玻璃体内注射贝伐单抗治疗年龄相关性黄斑变性中心凹下脉络膜新生血管：泛美视网膜协作研究组12个月随访结果

Retina. 2008 Nov-Dec;28(10):1387-94. doi: 10.1097/IAE.0b013e3181884ff4.

Short-term effectiveness of intravitreal bevacizumab versus ranibizumab injections for patients with neovascular age-related macular degeneration.玻璃体内注射贝伐单抗与雷珠单抗治疗新生血管性年龄相关性黄斑变性的短期疗效。

Retina. 2009 Oct;29(9):1235-41. doi: 10.1097/IAE.0b013e3181b20eed.

Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.玻璃体内注射贝伐单抗治疗年龄相关性黄斑变性伴色素上皮脱离的隐匿性脉络膜新生血管

Acta Ophthalmol Scand. 2006 Oct;84(5):713-4. doi: 10.1111/j.1600-0420.2006.00759.x.

Intravitreal bevacizumab.玻璃体内注射贝伐单抗。

Ophthalmology. 2007 Feb;114(2):400; author reply 400-1. doi: 10.1016/j.ophtha.2006.10.002.

A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.雷珠单抗玻璃体腔内注射可变剂量方案治疗新生血管性年龄相关性黄斑变性：PrONTO研究的第2年

Am J Ophthalmol. 2009 Jul;148(1):43-58.e1. doi: 10.1016/j.ajo.2009.01.024. Epub 2009 Apr 18.

Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.玻璃体内注射贝伐单抗治疗视乳头周围典型性视网膜下新生血管形成

Acta Ophthalmol Scand. 2007 May;85(3):340-1. doi: 10.1111/j.1600-0420.2006.00832.x.

引用本文的文献

Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis.抗血管内皮生长因子治疗视网膜疾病：系统评价和荟萃分析。

BMJ Open. 2019 May 28;9(5):e022031. doi: 10.1136/bmjopen-2018-022031.

Mortality associated with bevacizumab intravitreal injections in age-related macular degeneration patients after acute myocardial infarct: a retrospective population-based survival analysis.年龄相关性黄斑变性患者急性心肌梗死后玻璃体内注射贝伐单抗相关的死亡率：一项基于人群的回顾性生存分析。

Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):651-663. doi: 10.1007/s00417-018-3917-9. Epub 2018 Feb 10.

Bevacizumab and ranibizumab for neovascular age-related macular degeneration: an updated meta-analysis of randomised clinical trials.贝伐单抗和雷珠单抗治疗新生血管性年龄相关性黄斑变性：随机临床试验的最新荟萃分析

Graefes Arch Clin Exp Ophthalmol. 2014 Oct;252(10):1529-37. doi: 10.1007/s00417-014-2764-6. Epub 2014 Aug 22.

The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review.玻璃体内注射贝伐单抗单药治疗成人眼科疾病的安全性：系统评价

BMJ Open. 2014 Jul 17;4(7):e005244. doi: 10.1136/bmjopen-2014-005244.

Changing paradigms of anti-VEGF in the Indian scenario.改变印度抗 VEGF 治疗模式。

Indian J Ophthalmol. 2014 Jan;62(1):88-92. doi: 10.4103/0301-4738.126189.

FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity.FUSION 方案：雷珠单抗治疗初治渗出型年龄相关性黄斑变性且基线视力较好的患者。

Graefes Arch Clin Exp Ophthalmol. 2012 Dec;250(12):1737-44. doi: 10.1007/s00417-012-2009-5. Epub 2012 Apr 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验